BFAD FDA MEMORANDUM CIRCULAR 001 s. 1983

: The main purpose is to prevent the sale and distribution of substandard drugs in the domestic market by requiring retailers to procure stocks only from legitimate or authorized manufacturers or distributors.
: All drugstores, hospital pharmacies, wholesalers, and other retailers of drugs and medicines are required to do so.
: All transactions must be accompanied by a sales invoice indicating, among other details, the lot or batch number of the manufacturer's stocks.
: Stocks from illegitimate or unauthorized sources are deemed violative and not approved by the FDA, subject to outright seizure or confiscation as mandated by LOI No. 1223 dated April 12, 1982.
: LOI No. 1223 dated April 12, 1982, mandates the seizure or confiscation of such stocks.
: The FDA may take administrative and legal actions including prosecution of the owner, pharmacist, and others concerned, as well as closure of the drug establishment.
: Catalina C. Sanchez, Acting Administrator, signed the original issuance.
: It ensures traceability of the drugs and helps verify that stocks come from legitimate manufacturers, preventing the circulation of substandard or counterfeit drugs.
: It refers to entities legally recognized and approved by the FDA to manufacture or distribute drugs and medicines in the Philippines.